GE to boost cell therapy tech with Biosafe acquisition

GE to boost cell therapy tech with Biosafe acquisition

GE Healthcare has acquired Biosafe Group, a supplier of integrated cell bioprocessing systems, for an undisclosed amount. The acquisition will help GE in its plans to develop a digitally enabled offering of tools, solutions and services for cell therapy.

According to GE, this acquisition will expand the company’s “end-to-end ecosystem of products, solutions and services for our cell therapy customers” and expands GE’s reach to many new cell and therapy types.

Biosafe has been working in the automated cell processing arena and offers proprietary products that include advantages–such as closed fluid pathways, built-in traceability and single-use consumables–over conventional tech….

Source: Fiercebiotech

Plus

Leave a reply